BEONE MEDICINES USA, INC. (FORMERLY BEIGENE USA, INC.)

Lobbying for BEONE MEDICINES USA, INC (FORMERLY BEIGENE USA, INC.)

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $250,000.00 expenses · posted Apr 21, 2025

Lobbying activity 1

Health Issues

Issues related to drug pricing; Issues related to the drug approval and review process; issues related to operations of the Department of Veterans Affairs including work with clinical trials and research studies; implementation of the Inflation Reduction Act; the EPIC Act; ORPHAN Cures Act and pharmacy benefit manager legislation.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.